Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-804P (RNA, U6 small nuclear 804, pseudogene) is a pseudogene derived from the U6 small nuclear RNA (snRNA) gene family[2][5][6]. U6 snRNA is a highly conserved, essential component of the spliceosome complex responsible for the excision of introns from pre-mRNA in eukaryotic cells[1][3]. Pseudogenes such as RNU6-804P are non-coding, do not produce functional RNA or protein products, and lack canonical biological activity[2][5][7]. Some pseudogenes can regulate gene expression as decoys or through other non-coding RNA mechanisms, but there is no evidence to suggest that RNU6-804P has a regulatory or biological function, nor is it considered a therapeutic target[2][3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 804, pseudogene (RNU6-804P).